交易中 08-12 10:19:13 美东时间
+1.215
+0.51%
美国银行表示,美国主要保险公司的股票在经历了惨烈的下跌后,如今看起来即将反弹,原因是有吸引力的估值和盈利有望回升可能吸引投资者回归。
08-07 19:07
今日重点评级关注:Leerink Partners:维持Celcuity"跑赢大市"评级,目标价从28美元升至60美元;Macquarie:维持Churchill Downs"跑赢大市"评级,目标价从150美元升至155美元
07-29 09:30
Barclays analyst Alex Scott maintains RenaissanceRe Holdings (NYSE:RNR) with a Equal-Weight and raises the price target from $256 to $273.
07-24 20:08
RenaissanceRe Holdings (NYSE:RNR) reported quarterly earnings of $12.29 per share which beat the analyst consensus estimate of $9.67 by 27.15 percent. This is a 0.97 percent decrease over earnings of $12.41 per share
07-24 04:18
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to repor...
07-23 16:32
Morgan Stanley analyst Michael Phillips maintains RenaissanceRe Holdings (NYSE:RNR) with a Overweight and lowers the price target from $285 to $280.
07-14 21:55
今日重点评级关注:杰富瑞:维持Cogent Biosciences"买入"评级,目标价从23美元升至28美元;Leerink Partners:维持Cogent Biosciences"跑赢大市"评级,目标价从16美元升至18美元
07-08 09:34
Barclays analyst Alex Scott upgrades RenaissanceRe Holdings (NYSE:RNR) from Underweight to Equal-Weight and raises the price target from $231 to $256.
07-07 21:02
潜在涨幅300.0%!HC Wainwright & Co.:Armata Pharmaceuticals获机构升目标价至9美元,维持"买入"评级
05-21 16:44
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Armata Pharmaceuticals(ARMP)"买入"评级,目标价从7美元升至9美元</p> <p>• 瑞银:维持爱芬奇(ANF)"买入"评级,目标价从115美
05-20 09:28